Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Crown Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Crown Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 10
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Crown Bioscience Acquires PDX Business Unit from Molecular Response 13
Venture Financing 14
CBT Pharma Raises USD5 Million in Seed Financing 14
Crown Bioscience Raises Funds in Venture Financing 15
Crown Bioscience Raises USD27 Million in Series D Financing 16
Partnerships 17
Crown Bioscience Enters into Partnership Agreement with Pierre Fabre Research Institute 17
Crown Bioscience Enters into Partnership with Glycotope 18
Crown Bioscience Enters into Partnership with Phanes Therapeutics 19
Crown Bioscience Enters into Co-Development Agreement with Data Sciences International 20
Crown Bioscience and Jackson Lab Enter into Agreement 21
Crown Bioscience Enters into Agreement with Jiangsu Qyun Bio-Pharma 22
Crown Bioscience Expands Co-Development Agreement with NRCMM for Novel Immuno-oncology Mouse Models 23
Crown Bioscience Enters into Co-Development Agreement with NRCMM for New Cancer Models 24
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25
Crown Bioscience Enters Into Agreement With Beijing Purunao To Develop Cancer Drugs 26
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27
Crown Bioscience Enters Into Co-Development With Jiangsu Hengrui Medicine 28
Licensing Agreements 29
Crown Bioscience Enters into Licensing Agreement with University of Utah 29
Crown Bioscience Enters into Licensing Agreement with Shanghai Model Organisms 30
CBT Pharma Enters into Licensing Agreement with Crown Bioscience 31
Crown Bioscience Enters into Licensing Agreement with University of York 32
CBT Pharma Enters into Licensing Agreement with Crown Bioscience 33
Equity Offering 34
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 34
Crown Bioscience Raises Funds through IPO 35
Acquisition 36
JSR Acquires Crown Bioscience for USD399.7 Million 36
Crown Bioscience Acquires PreClinOmics 38
Crown Bioscience Acquires Preclinical Oncology Services 39
Crown Bioscience Inc – Key Competitors 40
Crown Bioscience Inc – Key Employees 41
Crown Bioscience Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Strategy And Business Planning 43
Jul 13, 2017: Crown Bioscience Expands its Life Science Portfolio 43
Jan 26, 2017: CrownBio Announces Expansion of Life Science Division 44
Jan 24, 2017: Crown Bioscience Announces Expansion of Therapeutic Expertise into Inflammation 45
Jan 12, 2017: Crown Bioscience Expands US Capacity for Cardiovascular & Metabolic Disease Research; Partners with New Iberia Research Center of Louisiana 46
Financial Announcements 47
Aug 10, 2017: Crown Bioscience Announces Second Quarter Results 47
May 19, 2017: Crown Bioscience Announces Record Breaking Growth With First 2017 Quarter Results 48
Corporate Communications 49
Nov 09, 2017: Crown Bioscience Announcing the 2017 Board of Directors Election Results Dr. Guoliang Yu re-elected as the Chairman 49
Sep 27, 2017: Crown Bioscience Names Laurie Heilmann Chief Business Officer; Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role 50
Aug 10, 2017: Crown Bioscience Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations 51
Government and Public Interest 52
Jul 19, 2018: Crownbio supports excellence in translational research with grant award that funds innovative PDX model development in immuno-oncology 52
Nov 17, 2017: CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research 53
Product News 54
Nov 23, 2017: Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring 54
Oct 10, 2017: CrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and Diabetes 55
Sep 13, 2017: CrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck Cancer 56
Aug 01, 2017: CrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical Research 57
Other Significant Developments 58
Sep 26, 2018: CrownBio completes validation of prostate cancer patient-derived xenograft (PDX) models 58
Jul 27, 2018: CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center 59
Feb 20, 2018: Crown Bioscience: CAR T-Cell Therapy Platform 60
Feb 09, 2018: Enhanced MuScreen Platform Revolutionizes Preclinical Development of Immunotherapeutics 61
Jan 09, 2018: Crown Bioscience Launches CrownSyn, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination Studies 62
Apr 19, 2017: Crown Bioscience Launches e-Commerce Platform to Commercialize its Life Science Products 63
Mar 09, 2017: Crown Bioscience Enables Secure Data Real Time Access with the Release of Client Facing Portal 64
Feb 16, 2017: Crown Bioscience Enhances Digital Connectivity with the Release of OncoExpress Technology Platform 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Crown Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Crown Bioscience Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Crown Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 10
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Crown Bioscience Acquires PDX Business Unit from Molecular Response 13
CBT Pharma Raises USD5 Million in Seed Financing 14
Crown Bioscience Raises Funds in Venture Financing 15
Crown Bioscience Raises USD27 Million in Series D Financing 16
Crown Bioscience Enters into Partnership Agreement with Pierre Fabre Research Institute 17
Crown Bioscience Enters into Partnership with Glycotope 18
Crown Bioscience Enters into Partnership with Phanes Therapeutics 19
Crown Bioscience Enters into Co-Development Agreement with Data Sciences International 20
Crown Bioscience and Jackson Lab Enter into Agreement 21
Crown Bioscience Enters into Agreement with Jiangsu Qyun Bio-Pharma 22
Crown Bioscience Expands Co-Development Agreement with NRCMM for Novel Immuno-oncology Mouse Models 23
Crown Bioscience Enters into Co-Development Agreement with NRCMM for New Cancer Models 24
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25
Crown Bioscience Enters Into Agreement With Beijing Purunao To Develop Cancer Drugs 26
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27
Crown Bioscience Enters Into Co-Development With Jiangsu Hengrui Medicine 28
Crown Bioscience Enters into Licensing Agreement with University of Utah 29
Crown Bioscience Enters into Licensing Agreement with Shanghai Model Organisms 30
CBT Pharma Enters into Licensing Agreement with Crown Bioscience 31
Crown Bioscience Enters into Licensing Agreement with University of York 32
CBT Pharma Enters into Licensing Agreement with Crown Bioscience 33
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 34
Crown Bioscience Raises Funds through IPO 35
JSR Acquires Crown Bioscience for USD399.7 Million 36
Crown Bioscience Acquires PreClinOmics 38
Crown Bioscience Acquires Preclinical Oncology Services 39
Crown Bioscience Inc, Key Competitors 40
Crown Bioscience Inc, Key Employees 41
Crown Bioscience Inc, Other Locations 42
Crown Bioscience Inc, Subsidiaries 42
List of Figures
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Crown Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Crown Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 10